Intravenous Solution Market Overview
In clinical medicine, intravenous solutions are commonly used to restore and maintain body fluids. They are given to people who have lost body fluids owing to dehydration or other medical conditions. Intravenous solutions are injected straight into the veins and provide immediate relief to those undergoing treatment. The global Intravenous Solution market is projected to rise at a significant rate in the forecast period.
Increased incidence of chronic and acute diseases, rise in the geriatric population, increase in strategic collaborations between manufacturers to enhance their product portfolio and geographical presence, expansion in the pharmaceutical industry, increase in demand for intravenous solutions from developing economies, and increase in health care expenditure are all major drivers of the global intravenous solutions market.
On the negative side, the global intravenous solution market is expected to be restrained over the forecast period due to factors such as a strict regulatory environment and high fluid maintenance costs.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Product, Composition, Distribution Channel, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Baxter, Fresenius Kabi, B. Braun Melsungen AG, ICU Medical, Inc., Grifols S.A, Pfizer. |
Covid-19 Impact on Intravenous Solution Market
In addition, the current Intravenous Solution Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Intravenous Solution Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Intravenous Solution Market Segment Overview
According to Product, Isotonic Solutions is one of the largest segments in the global Intravenous Solution market. There are several types of intravenous solutions on the market, including isotonic, hypertonic, and hypotonic. Isotonic solutions are made up of normal saline (0.9 NaCl) and are used to replace the extracellular fluid in the treatment of hypernatremia. As electrolyte replenishers, hypotonic intravenous solutions with 0.45 percent NaCl are utilized. Hypotonic solutions are used to treat dilutional hypernatremia and low sodium levels in severe situations.
Intravenous Solution Market, By Product
· Isotonic Solutions
· Hypotonic Solutions
· Hypertonic Solutions
Intravenous Solution Market, By Composition
· 9% Normal Saline
· Lactated Ringers
· 5% Dextrose in Water
· Others
Intravenous Solution Market, By Distribution Channel
· Hospital Pharmacies
· Drug Stores
· Retail Pharmacies
Intravenous Solution Regional Overview
Based on the region, the intravenous solution market in North America is expected to dominate the global market, followed by the intravenous solution market in Europe during the projected period. Increased incidence of chronic diseases, increased demand for intravenous solutions, and the presence of key manufacturers in the region are the major factors leading to the dominance of the two regions in the global intravenous solution market. During the forecast period, the market in the Asia Pacific is expected to create attractive prospects for manufacturers. Due to an increase in the patient population, the rapid expansion of the pharmaceutical industry in the region increased mergers and acquisitions, and increased government initiatives to promote better health care facilities in the region's developing economies, the market in the region is expected to grow at a rapid pace.
Intravenous Solution Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Intravenous Solution Market, Key Players
· Baxter
· Fresenius Kabi
· B. Braun Melsungen AG
· ICU Medical, Inc.
· Grifols S.A
· Pfizer
· other
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Intravenous Solution market?
Increased incidence of chronic and acute diseases, rise in the geriatric population, increase in strategic collaborations between manufacturers to enhance their product portfolio and geographical presence are some key factors that contributed towards the growth of the Intravenous Solution market
Q2. What are the restraining factors for the global Intravenous Solution market?
The global intravenous solution market is expected to be restrained over the forecast period due to factors such as a strict regulatory environment and high fluid maintenance costs.
Q3. Which segment is projected to hold the largest share in the global Intravenous Solution Market?
Isotonic Solutions segment is projected to hold the largest share in the global Intravenous Solution Market.
Q4. Which region holds the largest share in the global Intravenous Solution market?
North America held the largest share in the global Intravenous Solution market
Q5. Which are the prominent players in the global Intravenous Solution Market?
Baxter, Fresenius Kabi, B. Braun Melsungen AG, ICU Medical, Inc., Grifols S.A, Pfizer. are some key players in the global Intravenous Solution Market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Intravenous Solution Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Isotonic Solutions
- 5.2.2. Hypotonic Solutions
- 5.2.3. Hypertonic Solutions
- 5.3. Market Analysis, Insights and Forecast – By Composition
- 5.3.1. 9% Normal Saline
- 5.3.2. Lactated Ringers
- 5.3.3. 5% Dextrose in Water
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacies
- 5.4.2. Drug Stores
- 5.4.3. Retail Pharmacies
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Intravenous Solution Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Isotonic Solutions
- 6.2.2. Hypotonic Solutions
- 6.2.3. Hypertonic Solutions
- 6.3. Market Analysis, Insights and Forecast – By Composition
- 6.3.1. 9% Normal Saline
- 6.3.2. Lactated Ringers
- 6.3.3. 5% Dextrose in Water
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hospital Pharmacies
- 6.4.2. Drug Stores
- 6.4.3. Retail Pharmacies
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Intravenous Solution Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Isotonic Solutions
- 7.2.2. Hypotonic Solutions
- 7.2.3. Hypertonic Solutions
- 7.3. Market Analysis, Insights and Forecast – By Composition
- 7.3.1. 9% Normal Saline
- 7.3.2. Lactated Ringers
- 7.3.3. 5% Dextrose in Water
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hospital Pharmacies
- 7.4.2. Drug Stores
- 7.4.3. Retail Pharmacies
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Intravenous Solution Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Isotonic Solutions
- 8.2.2. Hypotonic Solutions
- 8.2.3. Hypertonic Solutions
- 8.3. Market Analysis, Insights and Forecast – By Composition
- 8.3.1. 9% Normal Saline
- 8.3.2. Lactated Ringers
- 8.3.3. 5% Dextrose in Water
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hospital Pharmacies
- 8.4.2. Drug Stores
- 8.4.3. Retail Pharmacies
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Intravenous Solution Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Isotonic Solutions
- 9.2.2. Hypotonic Solutions
- 9.2.3. Hypertonic Solutions
- 9.3. Market Analysis, Insights and Forecast – By Composition
- 9.3.1. 9% Normal Saline
- 9.3.2. Lactated Ringers
- 9.3.3. 5% Dextrose in Water
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hospital Pharmacies
- 9.4.2. Drug Stores
- 9.4.3. Retail Pharmacies
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Baxter
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Fresenius Kabi
- 10.6. B. Braun Melsungen AG
- 10.7. ICU Medical, Inc.
- 10.8. Grifols S.A
- 10.9. Pfizer
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
